CompletedNot Applicable

Surface Wear of PEEK Clasp Against Zirconia Full-Coverage Restored Abutments in Distal Extension Removable Partial Dentures

Egypt10 participantsStarted 2024-03-01

Plain-language summary

This prospective clinical comparative study will evaluate the surface wear of BioHPP (modified polyetheretherketone) clasps opposing either natural tooth abutments or zirconia full-coverage abutments in mandibular bilateral distal extension removable partial dentures. Ten participants will be randomly assigned to two equal groups. Surface topography changes of the clasp fitting surfaces will be assessed using scanning electron microscopy (SEM) at denture insertion, 6 months, and 12 months. The findings will help determine the influence of abutment material on the wear behavior of BioHPP clasps and provide evidence for selecting appropriate abutment materials in removable partial denture treatment.

Who can participate

Age range

40 Years – 50 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Adults aged 40-50 years. Mandibular Kennedy Class I partial edentulism. Bilateral distal extension edentulous areas. Presence of healthy canines and first premolars suitable as abutment teeth. Adequate oral hygiene and healthy periodontal condition. Adequate interarch space for removable partial denture fabrication. Ability and willingness to attend all scheduled follow-up visits and provide written informed consent. Exclusion Criteria: Systemic diseases or medications that could affect bone or soft tissue healing. Active periodontal disease or poor oral hygiene. Severe parafunctional habits (e.g., bruxism or clenching). Smoking. Pregnancy or lactation. Allergy or hypersensitivity to any study materials. Inability to comply with study procedures or follow-up visits.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Surface topography changes of BioHPP clasp fitting surfaces

Timeframe: Baseline (denture insertion), 6 months, and 12 months

Trial details

NCT IDNCT07708558

SponsorMansoura University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-09-01

View on ClinicalTrials.gov More Partial Edentulism trials